PharmTech News

Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.

Articles

There are no clinically meaningful differences between Celltrion’s CT-P13 and Remicade, according to an FDA briefing released ahead of the formal panel meeting.

Celltrion’s Biosimilar to Remicade Likely to be Approved for All Indications

Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.

In a hearing held on Feb. 4, 2016, executives from Valeant and Turing had a hard time explaining their rationales for exorbitant price hikes of older drugs.

Valeant and Turing Called Out on Drug Pricing

Caroline Hroncich was associate editor for Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International from 2015 to 2017.

Several biopharmaceutical companies announce plans to launch R&D into Zika vaccine candidates.

Biopharmaceutical Companies Announce Plans to Develop Zika Vaccine

Novartis announced the companies plan to boost growth at Alcon, the company’s vision care division.

Novartis Announces Plans to Accelerate Growth of Vision Care Division

NICE announces plans to back biosimilar alternatives to Merck’s Remicade.

NICE Announces Plans to Back Remicade Biosimilars

FDA’s Center for Drug Evaluation and Research publishes a list of upcoming new and revised guidance documents for 2016.

FDA’s CDER Previews 2016 Guidance Agenda

More than 80 pharmaceutical, biotechnology, generics, and diagnostics companies draft and sign the Declaration on Combating Antimicrobial Resistance.

Pharmaceutical Companies Sign Declaration to Combat Antimicrobial Resistance

Samsung Bioepis receives approval from the European Commission for the Enbrel Biosimilar, Benepali.

Samsung Bioepis Receives Approval in EU for Enbrel Biosimilar

The denial marks a setback for Amgen, who’s Humira biosimilar ABP 501 is the first submitted to FDA for adalimumab.

US Patent Office Denies Amgen’s Petition to Review Humira Patents

The British Standards Institution (BSI) and the Alliance for Clinical Research Excellence and Safety (ACRES) announced a collaboration to develop global standards of excellence for clinical research sites.

Top News